Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $574.03 ($4.8M) on 2026-04-16, disclosed to the SEC on 2026-04-16.
Scheduled sale ($4.8M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $574.03 | 200 | $115K | 2.4% |
| 2 | $575.37 | 1,640 | $944K | 19.7% |
| 3 | $576.38 | 1,800 | $1.0M | 21.7% |
| 4 | $577.39 | 3,366 | $1.9M | 40.6% |
| 5 | $578.21 | 1,294 | $748K | 15.6% |
| Total | $576.82 avg | 8,300 |
| $4.8M |
| 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |